parenteral nutrition associated liver disease (PNALD)
Showing 1 - 25 of >10,000
Parenteral Nutrition-related Hepatitis Trial in Kansas City (Omegaven)
Completed
- Parenteral Nutrition-related Hepatitis
-
Kansas City, MissouriChildren's Mercy Hospitals and Clinics
Jun 1, 2021
Omegaven in Pediatric Parenteral Nutrition-Associated
Withdrawn
- Parenteral Nutrition Associated Liver Disease
- +4 more
- Omegaven® (fish oil triglycerides) Injectable Emulsion
- (no location specified)
Aug 2, 2022
Cholestasis Trial in United States (Intralipid 20% I.V. Fat Emulsion)
Completed
- Cholestasis
- Intralipid 20% I.V. Fat Emulsion
-
Aurora, Colorado
- +4 more
Dec 14, 2020
Total Parenteral Nutrition-induced Cholestasis Trial in New York (Omegaven IV lipid emulsion)
Withdrawn
- Total Parenteral Nutrition-induced Cholestasis
- Omegaven IV lipid emulsion
-
New York, New YorkColumbia Presbyterian Medical Center-Children's Hospital of NY
Feb 4, 2020
Liver Disease in Patients Dependent on Parenteral Nutrition
Recruiting
- Intestinal Failure-associated Liver Disease
-
Los Angeles, California
- +8 more
Jul 7, 2022
Parenteral Nutrition Associated Liver Disease PNALD, Cholestasis Trial in Omaha (Omegaven™)
Completed
- Parenteral Nutrition Associated Liver Disease PNALD
- Cholestasis
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 4, 2019
Parenteral Nutrition Associated Liver Disease Trial (Omegaven)
Approved for marketing
- Parenteral Nutrition Associated Liver Disease
- Omegaven
- (no location specified)
May 7, 2021
Fatty Liver Disease, Obesity, Liver Fat Trial in Istanbul (Diet, Cornus mas L.(Cornelian Cherry))
Completed
- Fatty Liver Disease
- +2 more
- Diet
- Cornus mas L.(Cornelian Cherry)
-
Istanbul, Avcılar, TurkeyIstanbul Gelisim University
Sep 16, 2022
Metabolism and Nutrition Disorder, Liver Diseases, Obesity Trial in Shanghai (dietary intervention)
Not yet recruiting
- Metabolism and Nutrition Disorder
- +3 more
- dietary intervention
-
Shanghai, Shanghai, ChinaDepartment of Clinical Nutrition, Xinhua Hospital Affiliated to
Jul 1, 2022
Parenteral Nutrition Associated Liver Disease Trial in Boise (Omegaven)
No longer available
- Parenteral Nutrition Associated Liver Disease
-
Boise, IdahoSt. Luke's Pediatric Gastroenterology
Apr 8, 2019
Short Bowel Syndrome, Parenteral Nutrition Associated Liver Disease Trial in Leeds (NST 6179, Placebo)
Recruiting
- Short Bowel Syndrome
- Parenteral Nutrition Associated Liver Disease
- NST 6179
- Placebo
-
Leeds, United KingdomCovance Clinical Research Unit, Ltd
May 3, 2022
Parenteral Nutrition Associated Liver Disease Trial in Nashville (Omegaven)
Completed
- Parenteral Nutrition Associated Liver Disease
-
Nashville, TennesseeMonroe Carell Jr Children's Hospital at vanderbilt
Dec 11, 2020
Essential Fatty Acid Deficiency (EFAD) Trial in United States (Clinolipid, Intralipid)
Completed
- Essential Fatty Acid Deficiency (EFAD)
-
Mobile, Alabama
- +8 more
Jan 30, 2023
Steatohepatitis, Nonalcoholic Trial (Ultrasound)
Not yet recruiting
- Steatohepatitis, Nonalcoholic
- Ultrasound
- (no location specified)
Apr 23, 2021
How Well do we Feed the Critically Ill Patients
Not yet recruiting
- Enteral and Supplement Feeds Adverse Reaction
- +4 more
- Nutritional therapy
-
Dubai, United Arab EmiratesNMC Specialty Hospital, Al Nahda
Apr 23, 2022
Total Parenteral Nutrition-induced Cholestasis Trial in Park Ridge (Omegaven IV lipid emulsion)
Approved for marketing
- Total Parenteral Nutrition-induced Cholestasis
- Omegaven IV lipid emulsion
-
Park Ridge, IllinoisAdvocate Children's Hospital
Feb 15, 2019
Supplements SMOF in TPN for Liver Transplantation Recipients
Completed
- Liver Transplantation
- +2 more
- SMOFlipid
-
Kaohsiung, Niaosong District, TaiwanChang Gung Memorial Hospital
Oct 7, 2020
Short Bowel Syndrome Trial in Houston (elemental formula Elecare®, partially hydrolyzed formula)
Completed
- Short Bowel Syndrome
- elemental formula Elecare®
- partially hydrolyzed formula
-
Houston, TexasThe University of Texas Health Science Center at Houston
May 4, 2021
Cholestasis, Parenteral Nutrition Trial in Boston (Omegaven, Intralipid)
Completed
- Cholestasis
- Parenteral Nutrition
-
Boston, MassachusettsChildrens's Hospital Boston
Dec 1, 2020
Parenteral Nutrition Associated Cholestasis Trial in Sacramento (Omegaven)
Completed
- Parenteral Nutrition Associated Cholestasis
-
Sacramento, CaliforniaUniversity of California Davis Medical Center
Jan 25, 2021
Cholestasis of Parenteral Nutrition Trial in Indianapolis (Lipid Emulsions, Intravenous, Intralipid, 20% Intravenous Emulsion)
Active, not recruiting
- Cholestasis of Parenteral Nutrition
- Lipid Emulsions, Intravenous
- Intralipid, 20% Intravenous Emulsion
-
Indianapolis, IndianaRiley Hospital for Children at IU Health
Dec 27, 2021
Cholestasis Trial in Los Angeles (Omegaven)
Terminated
- Cholestasis
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Feb 11, 2020
Bone Markers in Pediatric IF
Recruiting
- Intestinal Failure
- +2 more
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Jun 9, 2023
Malnutrition, Hepatitis B,Chronic, Acute-On-Chronic Liver Failure Trial in Guangzhou (Individual nutritional support)
Recruiting
- Malnutrition
- +3 more
- Individual nutritional support
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital of Sun Yat-sen University
Nov 9, 2023
Essential Fatty Acid Deficiency (EFAD) Trial in United States (Clinolipid, Intralipid)
Terminated
- Essential Fatty Acid Deficiency (EFAD)
-
Park Ridge, Illinois
- +3 more
Jul 19, 2021